Juan Carlos Lopez-Talavera, MD, PhD

Juan Carlos Lopez-Talavera, M.D., Ph.D. is Chief Medical Officer of Fractyl Health.

Juan Carlos is a pharmaceutical expert in all aspects of research and development with more than 15 years of industry experience, from disease pathogenesis, target identification, pre-clinical and clinical development to medical affairs for marketed products. He has published more than 50 peer-reviewed original manuscripts.

Most recently, he served as Chief Medical Officer of Enterome Biosciences, where he led the company’s pipeline and clinical and pre-clinical development programs, clinical regulatory affairs, and patient engagement.

Prior to joining Enterome, he held positions of increasing responsibility in large pharma at Intercept Pharmaceuticals, AbbVie, Bristol Myers Squibb, and Roche Laboratories. He holds an M.D. and a Ph.D. in Hepatology from Universidad Autónoma de Barcelona.

You are now leaving the Fractyl.com website

You are leaving Fractyl’s main website to go to Fractyl’s U.K. site.

By selecting Continue you will be directed to Fractyl’s U.K. site. If you would like to remain on Fractyl’s main site, select the Cancel button.